Introduction
Leishmania/HIV coinfection is a new clinical form of leishmaniasis that has been reported in more than 35 countries [1, 2] HIV is a growing health problem in Sudan with an increasing prevalence in most regions of the country. In this manuscript we report the first patient diagnosed with L. major/HIV coinfection in Sudan.
Case report
This case report emerged from a large study on biotechnological typing of leishmania parasites in Sudan. The typing study was approved by the National Ethical Committee of the Federal Ministry of Health, Sudan. The approved protocol included obtaining consent of the participants for sample collection and HIV testing for unusual and severe clinical presentations to assist effective treatment and control. The patient in this case report gave written consent for HIV testing and enrolment in the typing study. Based on the severity of the presenting lesions he was suspected of HIV coinfection and was referred to the national HIV control programme for pre-counselling and HIV testing. Following the diagnosis of Leishmania/ HIV coinfection, the patient was provided with HIV counselling and free treatment by the national HIV control programme according the national guidelines.
A 38-year-old Sudanese male was referred to our laboratory at the Institute of Endemic Diseases during the last week of December 2007 for diagnosis of persistent ulcers. On clinical examination, the patient presented with 5 ulcers on his right arm, 3 on his left arm and a single lesion on his back. The ulcers were large, with necrotic and haemorrhagic zones (Figure 1 ). The patient had no fever or enlarged lymph nodes. The spleen and the liver were normal.
Tissue aspirates were collected from the periphery of the ulcers for preparation of smears and parasite culture. The parasite was typed based on the size of the amplified kDNA band using the method described by Smyth et al. [5] .
The Leishmanin skin test was done as described by Sokal [6] but was found to be negative. The presence of anti-HIV antibodies was determined using an enzyme-linked immunosorbent assay (ELISA) and Western blotting.
Leishmania/HIV coinfection was confirmed in the second week of January 2008. The patient was referred to the national HIV control programme for counselling and treatment.
Discussion
Our patient presented with unusually large multiple ulcers on both arms and his back. The ulcers had persisted for more than 3 months and were unresponsive to antibiotics. The patient lived ‫املتوسط‬ ‫لرشق‬ ‫الصحية‬ ‫املجلة‬ ‫عرش‬ ‫السادس‬ ‫املجلد‬ ‫الرابع‬ ‫العدد‬ in an area in central Sudan endemic for cutaneous leishmaniasis, which is about 100 km south of the capital, Khartoum. He had no history of travel to other parts of the country. Cutaneous leishmaniasis was confirmed by demonstration of the parasite in the lesion aspirates, which showed high parasitaemia. Furthermore, the parasite was successfully cultured in NNN media within 48 hours of inoculation of the media. The parasite was identified as L. major based on the amplification of a kDNA band of 700 bp identical to the reference strain [5] .
In Sudan, both L. Leishmania/HIV coinfection is a growing, serious health problem. Besides their resistance to conventional treatment, coinfected patients are a rich source for the transmission of the parasite. To our knowledge, this is the first report on L. major/HIV coinfection in Sudan and such coinfection should be considered in the management and control of cutaneous leishmaniasis in Sudan given the current surge of HIV infection.
